Philippe Halfon
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Philippe Halfon | |
|---|---|
 | |
| Born | |
| Nationality | French |
| Occupation(s) | Physician, researcher |
Philippe Halfon is the Head of Internal Medicine and Infectious Disease at the Hôpital Européen de Marseille.[1]
Career
[edit]Halfon received a PharmD in 1984 and PhD in 1999 from Aix-Marseille University. He also holds an MD from the University of Medicine of Marseille in 2006[citation needed]. He has previously worked and studied at the associated medical centre at Aix-Marseille University, later working in Infectious Disease in Montreal, Canada.[2]
He was previously appointed Research Director at Aix-Marseille University and an associate professor at Paris Hospital College.[citation needed] He was also a visiting Professor of Medicine at Emory University, United States[citation needed], and Hadassah Medical Centre, Israel.[3][4][5] His research focuses on cancer and virology, including SARS-CoV-2,[6] and he has published on these topics.[7]
Halfon is also the co-founder of biomedical sector companies Alphabio Clinical Laboratories,[8] Panmed Inc.,[2][dead link], and Genoscience Pharma, for which he is also the CEO.[9]
References
[edit]- ^ "Pôle hématologie, infectiologie et médecine interne". L’hôpital Européen. 22 October 2013. Retrieved 18 November 2020. [dead link]
- ^ a b "LO2A drops outperforms Systane on some measures treating DES patients suffering from Primary Sjogren". 1NewsReport. 23 November 2020. [dead link]
- ^ "Visiting Profesor Hebrew University".
- ^ "HIV carriers can now have healthy children thanks to innovative treatment at Hadassah medical center". Hadassah University Medical Center. Retrieved 17 November 2020. [dead link]
- ^ "Burden and prevention of Viral Hepatitis in Israel: Lessons learnt and the way forward" (PDF). Viral Hepatitis Prevention Board. Retrieved 17 November 2020.
- ^ "Coronavirus : une étude sur 100 patients marseillais pour "décrypter le dérèglement immunitaire"". La Provence. 16 April 2020. Retrieved 18 November 2020.
- ^ "Philippe Halfon articles". PubMed. Retrieved 18 November 2020.
- ^ "La réponse de Philippe Halfon, MD, PharmD, PhD, Chef de Pole de Médecine Interne et Maladies Infectieuses à l'Hôpital Européen, directeur du laboratoire Alphabio, Marseille Groupe Expert de Médecins de l'AMIF (GEMAMIF)". Association des Médecins Israélites de France. 23 March 2020. Retrieved 18 November 2020.
- ^ "Philippe Halfon, Md, Phd, Pharmd CEO And Founder Genoscience Pharma". lyfebulb. Retrieved 18 November 2020.
| International | |
|---|---|
| Other | |
